Image

Jill Ge

Partner

Email

jill.ge@aoshearman.com

Phone

+86 21 2036 7124

Offices

Shanghai

V-CARD
Jill covers the full spectrum of IP litigation and transactions relating to China. 

Jill has extensive experience in contentious patent, trade secret and trade mark matters involving multinationals and in resolving cross-border disputes. She has been involved with a broad spectrum of key and important dispute matters including crown-jewel big pharma patent litigation as well as bet-the-farm IP arbitration.

Jill is extremely versatile. Drawing on her litigation experience, Jill also routinely advises on IP and data-heavy transactions and counsels technology and life science clients in relation to their development of IP strategies, as well as related regulatory and competition law issues.

Jill has written extensively on IP developments in China, and one of her articles was quoted in an English Court of Appeal judgment (Conversant v Huawei). Jill has a technical background in physics and materials engineering. She studied law and was trained in the U.S. and qualified in the U.S. and China (non-practicing). Her international IP perspective and close collaboration with the global IP team is a unique asset when supporting our Chinese clients in overseas disputes.

 

 

Experience

Representative matters

A Chinese technology company in defending a US$120 million HKIAC claim commenced by a US company in relation to a technology transfer agreement. The claims were settled on favorable terms and without payment by our client.

A Fortune 500 manufacturing company in its defense against trademark infringement and cancellation claims brought by a local PRC company.

Stellantis on the IP and exclusive licensing aspects of its EV joint venture arrangement with Leapmotor.

Discovery Limited on the IP aspect of its joint venture with AIA Company Limited to establish a new health insurtech business across Asia Pacific.

RF Micro Devices (now Qorvo) on enforcing trade secrets against its former employees and the competing companies that they set up. This is believed to be the first parallel enforcement in China and the U.S. for trade secret violations.

A Chinese technology company in defending a US$100 million HKIAC claim commenced by a US company in relation to a technology transfer agreement.

TE Connectivity in defending a US$15 million trade mark infringement claim brought by a local Chinese company and multiple concurrent trade mark invalidation proceedings.

A multinational pharmaceutical corporation in appeals concerning the validity of a second medical use patent for its blockbuster Glivec drug.

Published Work

  • Co-author, “Commercially essential patents recognized as essential facility in China”, A&O alert, May 2021
  • Co-author, “China: Patent Law Amendment brings sea change to pharmaceutical patent regime”, A&O alert, November 2020
  • Author, “How a Chinese court would have decided the Unwired Planet appeal”, IAM Blog, November 2018
  • Author, “China: Does bifurcation mean patent validity has to be decided first?”, Comparative Patent Remedies, May 2018
  • Co-author, “The Patent Litigation Law Review, China Chapter – Edition 1”, The Law Reviews, January 2018
  • Author, “Damages trends in China: what the shifting landscape means for rights holders”, World Trademark Review Magazine, October 2017
  • Author, “China: Beijing IP Court publishes initial results of case precedent pilot project”, INTA Bulletin, September 2017
  • Co-author, “Iwncomm v Sony: first SEP-based injunction granted in China”, A&O alert, April 2017
  • Author, “The Beijing IP Court’s 50 million RMB judgment in WatchData v Hengbao”, Comparative Patent Remedies, January 2017
  • Co-author, “SEP-based injunction, down but not out”, Kluwer Patent Blog, April 2016 

Speaking Engagements

  • Speaker, Patent Linkage in China – Protecting Innovation or Accelerating Patent Cliff?, 28th Annual Fordham IP Conference, 09/04/2021
  • Panelist, IP in China, 27th Annual Fordham IP Conference, 25/04/2018
  • Speaker, Chinese Supreme Court’s recent cases – ad hoc decisions or path for the future?, 26th Annual Fordham IP Conference, 05/04/2018
  • Panelist, Recent Developments in Standard-Essential Patents in China, USPTO/Federal Circuit Bar Association webinar, 25/07/2017
  • Speaker, Patent damages in China – “Crossing the river by feeling the stones”, 25th Annual Fordham IP Conference, 18/04/2017

Leadership Positions And Professional Affiliations

  • Admitted to New York Bar, 2012 Qualified in China (non-practicing), 2020
Recognition
“Jill Ge upholds a rigorous and innovative attitude, treats every detail of the case prudently, and is good at finding breakthroughs in cases with innovative thinking. Her persistent and hardworking attitude is admirable”
Legal 500 Greater China, 2024

Qualifications

Admissions

Admitted to New York Bar, 2012

Qualified in China (non-practicing), 2020

Academic

J.D., cum laude, University of Minnesota Law School 

M.S., Materials Science and Engineering, University of California, Irvine 

B.S., Physics, Fudan University

Languages

Chinese (Mandarin), English
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.